Skip to main content

4 Result(s)

within L Sanhes Remove this filter

and

  1. Article

    Open Access

    Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

    M Hunault-Berger, N Maillard, C Himberlin, C Recher… in Blood Cancer Journal (2017)

    Download PDF (151 KB) View Article

  2. No Access

    Article

    Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

    After failure of erythropoiesis-stimulating agents (ESAs), lenalidomide (LEN) yields red blood cell (RBC) transfusion independence (TI) in 20–30% of lower-risk non-del5q myelodysplastic syndrome (MDS). Several...

    A Toma, O Kosmider, S Chevret, J Delaunay, A Stamatoullas, C Rose… in Leukemia (2016)

  3. No Access

    Article

    Incidence and prognostic value of respiratory events in acute leukemia

    Acute respiratory failure and infectious pneumonia are the major causes of death during induction chemotherapy of acute leukemia. However, the causes, incidence and prognostic value of all respiratory events (...

    D Chaoui, O Legrand, N Roche, M Cornet, A Lefebvre, R Peffault de Latour… in Leukemia (2004)

  4. No Access

    Article

    Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases

    B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of growth arrested clonal B lymphocytes that undergo apoptosis when treated with fludarabine. To further explore the mechanism f...

    L Sanhes, R Tang, A Delmer, J A DeCaprio, F Ajchenbaum-Cymbalista in Leukemia (2003)